BioSpace News Archive

Vimian delivers another solid quarter with 70 per cent revenue growth to EUR 67 million, and an adjusted EBITA margin of 26.4 per cent.

Devyser reported another quarter of strong organic growth, which again saw record-breaking sales.

During Q2 Immunovia built on our front-runner position in early detection of pancreatic cancer to ensure the execution of a successful commercial US launch by significantly strengthening our US team through the addition of new highly experienced hires.

United Therapeutics Corporation, a public benefit corporation, announced that four posters and one oral presentation will be presented at the European Society of Cardiology Congress 2022, taking place August 26-29, 2022, and the European Respiratory Society International Congress 2022, taking place September 4-6, 2022.

Johnson & Johnson announced the appointment of Larry Merlo as Non-executive Chair Designate for the future, listed New Consumer Health Company’s Board of Directors.

Cara Therapeutics, Inc. today announced the Company will host a virtual event focused on notalgia paresthetica (NP) on Tuesday, September 20, 2022, from 11:00 a.m. to 12:15 p.m. ET.

Bio-Techne Corporation (NASDAQ: TECH) today announced that it has been included in the Forbes list of Best-in-State Employers 2022.

Covalon Technologies Ltd. will release its Q3 Fiscal 2022 financial results on Monday, August 29th, 2022, before markets open.

Oragenics, Inc. today announced favorable preliminary results from its ongoing Good Laboratory Practice (GLP) toxicology study to evaluate the safety profile and immunogenicity of its NT-CoV2-1 vaccine candidate in rabbits.

Repligen Corporation today announced that it will host “Repligen Investor Day 2022” on Tuesday, September 20. The live event will take place at the Nasdaq MarketSite in New York City from 8:20 to 11:30 a.m. EDT.